Carregant...
Intravenous Artesunate for the Treatment of Severe and Complicated Malaria in the United States: Clinical Use under an Investigational New Drug Protocol
BACKGROUND: Quinidine gluconate, the only FDA-approved treatment for life-threatening malaria in the United States, has a problematic safety profile and is often unavailable in hospitals. OBJECTIVE: Assess the safety and clinical benefit of intravenous artesunate as a quinidine alternative DESIGN: R...
Guardat en:
| Publicat a: | Ann Intern Med |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4627466/ https://ncbi.nlm.nih.gov/pubmed/26301474 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7326/M15-0910 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|